We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$204M
2
TSM icon
TSMC
TSM
+$94.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$58M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$23M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$17.9M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$52.8M
2
AAPL icon
Apple
AAPL
+$32.5M
3
MSFT icon
Microsoft
MSFT
+$16.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
DIS icon
Walt Disney
DIS
+$14.2M

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONCT
4301
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$11K ﹤0.01%
+712
New +$14K
OHAA
4302
DELISTED
OPY Acquisition Corp. I Class A Common Stock
OHAA
$11K ﹤0.01%
1,111
– –
THRN
4303
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$11K ﹤0.01%
2,438
-1,064
-30% -$4.68K
QUOT
4304
DELISTED
Quotient Technology Inc
QUOT
$11K ﹤0.01%
3,301
-21,576
-87% -$76.6K
PRDS
4305
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$11K ﹤0.01%
8,678
+2,093
+32% +$3.42K
IRNT
4306
DELISTED
IronNet, Inc.
IRNT
$11K ﹤0.01%
31,712
-4,733
-13% -$1.86K
NOVN
4307
DELISTED
Novan, Inc. Common Stock
NOVN
$11K ﹤0.01%
8,691
-6,049
-41% -$8.4K
DOMA
4308
DELISTED
Doma Holdings, Inc.
DOMA
$11K ﹤0.01%
1,055
+245
+30% +$3.29K
TCRR
4309
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$11K ﹤0.01%
7,678
+741
+11% +$998
AUD
4310
DELISTED
Audacy, Inc.
AUD
$11K ﹤0.01%
78,621
+30,747
+64% +$7.07K
OIG
4311
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$11K ﹤0.01%
1,822
+305
+20% +$2.03K
ATHX
4312
DELISTED
Athersys, Inc. Common Stock
ATHX
$11K ﹤0.01%
9,246
-146
-2% -$208
SWI
4313
DELISTED
SolarWinds Corporation Common Stock
SWI
$11K ﹤0.01%
1,280
+796
+164% +$7.41K
BSQR
4314
DELISTED
BSQUARE Corporation
BSQR
$11K ﹤0.01%
10,467
+594
+6% +$714
ACXP icon
4315
Acurx Pharmaceuticals
ACXP
$6.06M
$10K ﹤0.01%
145
– –
ADVM
4316
DELISTED
Adverum Biotechnologies
ADVM
$10K ﹤0.01%
1,528
-986
-39% -$6.97K
AEG icon
4317
Aegon
AEG
$14B
$10K ﹤0.01%
2,427
-5,389
-69% -$27.3K
AIRI icon
4318
Air Industries Group
AIRI
$12.3M
$10K ﹤0.01%
2,620
+814
+45% +$3.85K
AKYA
4319
DELISTED
Akoya BioSciences
AKYA
$10K ﹤0.01%
1,243
-377
-23% -$3.94K
ALRS icon
4320
Alerus Financial
ALRS
$837M
$10K ﹤0.01%
651
+240
+58% +$4.75K
APCX
4321
DELISTED
AppTech Payments
APCX
$10K ﹤0.01%
6,742
+2,032
+43% +$4.92K
AQB icon
4322
AquaBounty Technologies
AQB
$7.93M
$10K ﹤0.01%
839
+737
+723% +$11.9K
ARTL icon
4323
Artelo Biosciences
ARTL
$2.86M
$10K ﹤0.01%
229
+138
+152% +$7K
ASLE icon
4324
AerSale
ASLE
$278M
$10K ﹤0.01%
575
-1,234
-68% -$21.9K
AUDC icon
4325
AudioCodes
AUDC
$254M
$10K ﹤0.01%
680
-16,275
-96% -$277K
171 172
173
174 175

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.